QQ客服 官方微博 反馈留言

	A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
	Zhang, Fengchun; Bae, Sang-Cheol; Bass, Damon; Chu, Myron; Egginton, Sally; Gordon, David; Roth, David A.; Zheng, Jie; Tanaka, Yoshiya
	2018
卷号	77期号:3页码:355-363
关键词	Disease Activity Systemic Lupus Erythematosus Treatment
ISSN号	0003-4967
DOI	10.1136/annrheumdis-2017-211631
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6361382
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhang, Fengchun,Bae, Sang-Cheol,Bass, Damon,et al. A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea[J],2018,77(3):355-363.
APA	Zhang, Fengchun.,Bae, Sang-Cheol.,Bass, Damon.,Chu, Myron.,Egginton, Sally.,...&Tanaka, Yoshiya.(2018).A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.,77(3),355-363.
MLA	Zhang, Fengchun,et al."A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea".77.3(2018):355-363.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。